Christine E. Szarka

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.

Gary R. Hudes, Christine E. Szarka, Andrea L. Adams et al. · PubMed · 2000 · 98 citations

Tumor Biology, Oncology, Chemoprevention Strategy +14

Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

P J O'Dwyer, Christine E. Szarka, Kang-Shen Yao et al. · Journal of Clinical Investigation · 1996 · 84 citations · Full text

Oncology, Chemoprevention Strategy, Medicine +13

Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer.

Christine E. Szarka, Gordon R. Pfeiffer, Susan Hum et al. · PubMed · 1995 · 77 citations

Immunotoxicology, Chemoprevention Strategy, Immunology +18

Preclinical and clinical evaluation of broccoli supplements as inducers of glutathione S-transferase activity.

Margie L. Clapper, Christine E. Szarka, Gordon R. Pfeiffer et al. · PubMed · 1997 · 45 citations

Nutrition, Dietary Exposure, Chemoprevention Strategy +16

Pharmacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose.

P J O'Dwyer, Christine E. Szarka, James M. Brennan et al. · PubMed · 2000 · 20 citations

Steady State, Pharmacological Study, Medicine +13